96 related articles for article (PubMed ID: 17136009)
1. Overexpression of aldose reductase in human cancer tissues.
Saraswat M; Mrudula T; Kumar PU; Suneetha A; Rao Rao TS; Srinivasulu M; Reddy B
Med Sci Monit; 2006 Dec; 12(12):CR525-529. PubMed ID: 17136009
[TBL] [Abstract][Full Text] [Related]
2. Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.
Reddy KA; Kumar PU; Srinivasulu M; Triveni B; Sharada K; Ismail A; Reddy GB
Breast; 2017 Feb; 31():137-143. PubMed ID: 27855345
[TBL] [Abstract][Full Text] [Related]
3. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of class I histone deacetylases in human cancer tissues.
Nakagawa M; Oda Y; Eguchi T; Aishima S; Yao T; Hosoi F; Basaki Y; Ono M; Kuwano M; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Oct; 18(4):769-74. PubMed ID: 17786334
[TBL] [Abstract][Full Text] [Related]
6. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer.
Tai HL; Lin TS; Huang HH; Lin TY; Chou MC; Chiou SH; Chow KC
Oncol Rep; 2007 Feb; 17(2):305-11. PubMed ID: 17203165
[TBL] [Abstract][Full Text] [Related]
8. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.
Crosas B; Hyndman DJ; Gallego O; Martras S; Parés X; Flynn TG; Farrés J
Biochem J; 2003 Aug; 373(Pt 3):973-9. PubMed ID: 12732097
[TBL] [Abstract][Full Text] [Related]
9. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.
Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF
Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
Shrivastav A; Varma S; Senger A; Khandelwal RL; Carlsen S; Sharma RK
J Pathol; 2009 Jul; 218(3):391-8. PubMed ID: 19360752
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
12. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage.
Kang ES; Woo IS; Kim HJ; Eun SY; Paek KS; Kim HJ; Chang KC; Lee JH; Lee HT; Kim JH; Nishinaka T; Yabe-Nishimura C; Seo HG
Free Radic Biol Med; 2007 Aug; 43(4):535-45. PubMed ID: 17640564
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
16. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
[TBL] [Abstract][Full Text] [Related]
17. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
19. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]